Victoza is approved to treat type 2 diabetes when used with diet and exercise and reduce cardiovascular risk in adults with type 2 diabetes and heart disease
Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH
LaPelusa, A., & Kaushik, R
Ghrelin and Synthetic GH Secretagogues Protect Rat Hearts From Ischemic Damage. Basic research in cardiology.Study breakdown PubMed 10RPEP-08773Lu, Zengbing et al
& Stremmel, W
Wound healing capacity in different tissues [1,2,1017] (including blood vessels) (i.e., stimulation of the early growth response 1 (egr-1) gene and its co-repressor nerve growth factor 1-A binding protein-2 (naB2) [17] also responsible for cytokine and growth factor generation and thereby, early extracellular matrix (collagen) and blood vessel formation [17]) and endothelium protection [1,2,14,15] were implicated in these counteracting effects